Search
for

    Learn

    5 / 801 results

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Minoxidil

      An essential vasodilator with some anti-androgenic effects, has excellent safety record

      learn HMI-115

      much-hyped research compound targeting prolactin receptor in scalp

      learn PP405

      mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials

    Research

    5 / 35 results

    Community Join

    5 / 562 results

      community Kintor long term safety phase 3

      in Research/Science  66 upvotes 1 year ago
      Kintor's phase III trial for pyri (KX-826) showed promising safety and efficacy results, with no drug-related sexual dysfunction reported. Users discussed their experiences with pyri, Minoxidil, Dutasteride, and concerns about the validity of the study results.

      community New Study Fails to Show Benefits of Microneedling in Males with Balding.

      in Treatment  157 upvotes 2 years ago
      A new study suggests microneedling alone doesn't benefit male balding, but users argue the study's methods differ from common practices, like combining microneedling with minoxidil and using more frequent treatments. Some believe the study's short duration and infrequent sessions are inadequate to assess microneedling's effectiveness.

      community Is Pyri worth it at the moment?

      in Chat  26 upvotes 2 years ago
      The conversation is about the effectiveness and safety of a hair loss treatment called Pyri, with users discussing its availability and comparing it to other treatments like RU58841, fluridil, and alfatradiol. Some users are waiting for FDA approval before using Pyri, while others share their positive experiences with RU58841 and suggest additional treatments with minimal side effects.

      community Will PP405 render Minox and Fin obsolete?

      in Research/Science  26 upvotes 9 months ago
      PP405 might make minoxidil unnecessary, but finasteride or other 5AR inhibitors may still be needed. PP405 is expected to be expensive and not available until at least 2028, with limited information on its effectiveness.